Quinazoline antifolates inhibiting thymidylate synthase: 2-desamino derivatives with enhanced solubility and potency
Authors:
- Timothy J. ThorntonTTTimothy J. Thornton
- Anthony FlinnAFAnthony Flinn
- Ann L. JackmanAJAnn L. Jackman
- D. R. NewellDND. R. Newell
- A. Hilary CalvertACA. Hilary Calvert
- 1 April 1989
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 32 (4) , 847-852
Abstract
The poor solubility of the thymidylate synthase (TS) inhibiting antifolate 10-propargyl-5,8-dideazafolic acid has posed problems for its clinical use and is probably responsible for its renal toxicity. The insolubility is caused by the 2-amino-3,4-dihydro-4-oxopyrimidine moiety of the drug which stabilizes the solid state by intermolecular hydrogen bonding. In examining this moiety we have removed the 2-amino group and now report on 2-desamino-10-propargyl-5,8-dideazafolic acid (8e) and four analogues with H, Me, Et, and allyl at N10. 3,4-Dihydro-4-oxo-6-methylquinazoline was solubilized by alkylating the lactam nitrogen with chloromethyl pivalate. Reaction with N-bromosuccinimide gave the corresponding 6-bromomethyl compound, which was coupled with diethyl N-(4-aminobenzoyl)-L-glutamate or the appropriate N-substituted derivative thereof. The quinazoline N3 nitrogen and carboxyl groups in the product was simultaneously deprotected by cold alkali in the final step to give the desired five antifolates. These were tested against L1210 TS and it was found that removal of the 2-amino group caused a slight (3-9-fold) loss of TS inhibition. 8e was noly 8-fold a lesser TS inhibitor than the parent drug. Inhibition of rat liver dihdyrofolate reductase was reduced by over 1 order of magnitude for three compounds tested. All five analogues were more cytotoxic to L1210 cells in culture than their 2-amino counterparts; 8e was 8.5-fold more active with an ID50 of 0.4 .mu.M. This remarkable result probably owes to increased cellular penetration, 8e was 5-fold more soluble than 1 at pH 5.0 and > 340-fold more soluble at pH 7.4.Keywords
This publication has 16 references indexed in Scilit:
- INCREASED THYMIDYLATE SYNTHASE IN L1210 CELLS POSSESSING ACQUIRED-RESISTANCE TO N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID (CB3717) - DEVELOPMENT, CHARACTERIZATION, AND CROSS-RESISTANCE STUDIES1986
- Quinazoline antifolates inhibiting thymidylate synthase: variation of the N10 substituentJournal of Medicinal Chemistry, 1985
- Hydrogen bonding and biological specificity analysed by protein engineeringNature, 1985
- Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-((2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino)benzoyl)-l-glutamic acid (CB3717), on human lymphoblastoid cellsBiochemical Pharmacology, 1983
- Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. I. General features and binding of methotrexate.Journal of Biological Chemistry, 1982
- A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in mice1981
- Primary structure of chicken liver dihydrofolate reductaseBiochemistry, 1980
- Porcine liver dihydrofolate reductase. Purification, properties, and amino acid sequence.Journal of Biological Chemistry, 1979
- Analogs of methotrexateJournal of Medicinal Chemistry, 1979
- INTRINSIC RESISTANCE TO METHOTREXATE OF CULTURED MAMMALIAN-CELLS IN RELATION TO INHIBITION KINETICS OF THEIR DIHYDROFOLATE REDUCTASES1976